Document is current
Any future updates will be listed below
-
Authors
Gadoth, Avi https://orcid.org/0000-0003-1917-9349
Segal, Yahel
Paran, Yael
Aizenstein, Orna
Alcalay, Yifat
- License Information
-
More Information
Article History
Received: 12 November 2021
Revised: 26 December 2021
Accepted: 13 January 2022
First Online: 25 January 2022
Declarations
:
: AG has a patent for MAP1B as the antigen for PCA-2-associated paraneoplastic syndrome and as a biomarker for SCLC which is diagnosed by IFA (1 patient in this study). YS, YP, OA, YA have no conflict of interest.
